What to do after a high cardiovascular risk result?

Getting a high cardiovascular risk result isn't an inevitable fate — it's a concrete invitation to act, with real options available, and a fairly well-established order of priority in the medical literature.

First, talk to a healthcare professional

A high or very high risk result obtained from a screening tool like this one deserves to be discussed with a doctor, who can refine the assessment (a full blood panel if needed, a clinical exam) and consider next steps on a personalized basis. This result isn't a diagnosis — it's a starting point for that conversation, not something to put off indefinitely or interpret alone without medical context.

First-line measures: acting on modifiable factors

Even before considering medication, managing cardiovascular risk relies on concrete action on the modifiable factors already identified:

• Quitting smoking, if applicable — the modifiable factor with the fastest and clearest impact, with measurable benefits within the first few weeks
• Improving diet and physical activity, two levers that act simultaneously on several risk factors (weight, blood pressure, cholesterol, blood sugar)
• Better control of blood pressure and cholesterol, often through lifestyle adjustments first, before considering medication if these measures prove insufficient

Concrete numerical targets to guide you

The 2021 European guidelines give concrete reference points, which the doctor adapts to each situation:

• Smoking: complete cessation, regardless of how much was smoked.
• Physical activity: at least 150 to 300 minutes a week of moderate-intensity activity, such as brisk walking, with less time spent sitting.
• Blood pressure: under 140/90 mmHg for everyone, and ideally around 130/80 mmHg if treatment is well tolerated.
• LDL-cholesterol: under 1.0 g/L (about 100 mg/dL) for high risk, and under 0.70 g/L (about 70 mg/dL) for very high risk.
• Diet: a Mediterranean-style pattern, under 5 g of salt a day, and limited alcohol consumption.

These targets are reached in steps. The guidelines actually propose a two-stage approach: first, targets that apply to everyone, then stricter targets, discussed with the doctor based on risk level and personal preferences.

What to expect from each measure

These efforts have effects measured by large studies. Lowering systolic blood pressure by 10 mmHg reduces the risk of a major cardiovascular event by about 20%, according to a review of 123 trials published in 2016 in The Lancet (Ettehad et al.). Each 0.4 g/L (1 mmol/L) reduction in LDL-cholesterol under statin treatment lowers this risk by about 22%, according to analyses by the Cholesterol Treatment Trialists' Collaboration. A Mediterranean diet reduced it by about 30% in the Spanish PREDIMED trial. And one year after quitting smoking, the excess risk of heart attack is already cut in half.

These benefits add up. Someone who quits smoking and lowers their blood pressure and cholesterol can cut their risk in half, or more.

When medication comes into play

Depending on the risk level obtained and age, statin treatment (medication that lowers cholesterol) may be considered for primary prevention — that is, before any cardiovascular event. Current European guidelines specify that, from age 70, this type of treatment may be considered for high or very high risk. This decision is always individualized, made together with the doctor, taking into account expected benefits, possible side effects, and the person's preferences — it is never an automatic prescription mechanically triggered by a number.

The specific role of each factor in the strategy

Not all risk factors are treated the same way or with the same urgency. Severe high blood pressure, for example, often needs faster management than moderate sedentary behavior, because of its more direct and immediate impact on the artery wall. This is why an individual assessment by a healthcare professional remains valuable for setting priorities, rather than trying to correct everything at once — an approach that can be discouraging and less effective than a staged, targeted progression.

The importance of regular biological follow-up

Beyond lifestyle measures and any medication, regular biological follow-up — lipid panel, blood sugar, kidney function depending on the risk factors identified — makes it possible to concretely check the effect of the measures put in place, and adjust the strategy if targets aren't met. This follow-up isn't meant to cause anxiety: on the contrary, it's an objective steering tool, which avoids navigating blindly based solely on sensations or impressions, which are often unreliable for judging the actual progress of factors like blood pressure or cholesterol.

Juggling several changes without getting discouraged

Faced with a high-risk result involving several factors to correct at once (smoking, weight, sedentary behavior, for example), it's tempting to want to change everything at once — an approach that often fails, for lack of enough attention and motivation to carry out several changes at the same time. The most effective approaches documented in the behavior-change literature generally favor clear prioritization: identify the factor with the greatest potential impact (often smoking, as detailed on the dedicated blog), address it first, then move on gradually to the next factors rather than tackling everything in parallel.

The primary care doctor's role as coordinator

Faced with a risk profile involving several factors, the primary care doctor often plays a central coordinating role, referring to specialists when needed (cardiologist, endocrinologist, tobacco cessation specialist, dietitian) while keeping an overall view of the situation. This coordination avoids the pitfall of fragmented care, where each factor would be treated in isolation without considering how they interact — a less effective approach than a coherent, overall strategy.

Long-term follow-up matters as much as the initial result

Managing cardiovascular risk isn't a one-time action: it's follow-up over the long term, with regular biological check-ups to assess how effective the measures put in place are, and readjustment if needed. Cardiovascular disease often progresses silently for several years before showing up — which is exactly what makes this preventive follow-up useful, rather than waiting for symptoms that, for many people, unfortunately appear at the very moment of the cardiovascular event itself.

Knowing the warning signs

Knowing how to react is also part of prevention. In France, call 15 (or 112) right away for chest pain or tightness lasting more than a few minutes, sometimes spreading to the arm, jaw, or back, especially if accompanied by shortness of breath, sweating, or nausea. In women, the signs are sometimes less typical: unusual fatigue, shortness of breath, pain in the upper abdomen. Also call for sudden paralysis or numbness of the face, an arm, or a leg, or sudden trouble speaking or seeing, which can indicate a stroke. In the United States, the emergency number is 911. Every minute gained improves the chances of recovery.

What to remember

A high risk today isn't a fixed trajectory. The modifiable factors identified — and individually assessable through the hub's other tools — represent real levers for action, with demonstrated benefits when put into practice, alone or combined with treatment when indicated. The key remains starting this process with the support of a healthcare professional, rather than navigating alone a result that, however statistically precise, always benefits from being put in context by a medical perspective.

To get your own estimate, take the “What's my cardiovascular risk?” test.